That’s the median weight loss experienced by people who take Wegovy, a drug from Novo Nordisk.
Many patients started by taking Ozempic, a diabetes drug also by Novo Nordisk that led to weight loss as a side effect.
Mounjaro, made by Eli Lilly and approved for treating diabetes, is expected to be approved soon for obesity.
While price and insurance coverage pose problems for patients, health economists expect prices to come down as more drugs are approved and companies face competition.
Medicare is forbidden by law to pay for weight-loss drugs, although there is an intense lobbying effort to change that.
Persons:
Eli Lilly, David A, Eli Lilly’s, “, ”, Ania, Robert F, Kushner
Organizations:
Novo Nordisk, Duke University, Yale University, Northwestern University Feinberg School of Medicine, “
Locations:
Novo